TransGenex Nanobiotech Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
TransGenex Nanobiotech General Information
Description
Developer of nano-scale technologies intended for diagnostic and therapeutic agents against cancers and other inflammatory diseases. The company develops a fiber-inspired scaffold technology platform that enables the development of multicellular tumor spheroids that fully resemble tumors in vivo, providing cancer patients with improved drug discovery and development, as well as better prediction of the clinical efficacy of drugs for personalized cancer treatment.
Contact Information
Website
www.transgenex.comCorporate Office
- 13719 North Nebraska Avenue
- Tampa, FL 33613
- United States
Corporate Office
- 13719 North Nebraska Avenue
- Tampa, FL 33613
- United States
TransGenex Nanobiotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 18-Jun-2015 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2015 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2009 | $427K | Completed | Startup | ||
| 1. Grant | 01-Jan-2008 | $1.03M | Completed | Startup |
TransGenex Nanobiotech Comparisons
Industry
Financing
Details
TransGenex Nanobiotech Competitors (3)
One of TransGenex Nanobiotech’s 3 competitors is Aspect Biosystems, a Venture Capital-Backed company based in Vancouver, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| Prellis Biologics | Venture Capital-Backed | Berkeley, CA | ||||
| InSphero | Private Equity-Backed | Schlieren, Switzerland |
TransGenex Nanobiotech Patents
TransGenex Nanobiotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200323949-A1 | Molecular engineering of a novel ternary complex of actinomycin d for cancer stem cells treatment | Inactive | 10-Apr-2019 | ||
| US-20220185767-A1 | Novel ternary molecular complex of tamibarotene for cancer stem cells treatment | Inactive | 02-Apr-2019 | ||
| WO-2020205957-A1 | Novel ternary molecular complex of tamibarotene for cancer stem cells treatment | Inactive | 02-Apr-2019 | ||
| US-11319311-B2 | Crystalline forms of actinomycin d for treatment of cancer | Inactive | 13-Feb-2018 | ||
| US-11053254-B2 | Crystalline forms of mitomycin c for treatment of cancer | Inactive | 13-Feb-2018 | C07D487/14 |
TransGenex Nanobiotech Signals
TransGenex Nanobiotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Institute for Commercialization of Florida Technology | Not-For-Profit Venture Capital | Minority | ||
| United States Department of War | Government | |||
| U.S. Department of Health and Human Services | Government |
TransGenex Nanobiotech FAQs
-
When was TransGenex Nanobiotech founded?
TransGenex Nanobiotech was founded in 2004.
-
Where is TransGenex Nanobiotech headquartered?
TransGenex Nanobiotech is headquartered in Tampa, FL.
-
What is the size of TransGenex Nanobiotech?
TransGenex Nanobiotech has 6 total employees.
-
What industry is TransGenex Nanobiotech in?
TransGenex Nanobiotech’s primary industry is Drug Discovery.
-
Is TransGenex Nanobiotech a private or public company?
TransGenex Nanobiotech is a Private company.
-
What is TransGenex Nanobiotech’s current revenue?
The current revenue for TransGenex Nanobiotech is .
-
Who are TransGenex Nanobiotech’s investors?
Institute for Commercialization of Florida Technology, United States Department of War, and U.S. Department of Health and Human Services have invested in TransGenex Nanobiotech.
-
Who are TransGenex Nanobiotech’s competitors?
Aspect Biosystems, Prellis Biologics, and InSphero are competitors of TransGenex Nanobiotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process